BlackRock Japan’s Ironwood Pharmaceuticals IRWD Stock Holding History

BlackRock Japan’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$50K	Buy	3,923 +494	+14%	+$6.24K	﹤0.01%	982
2016 Q3	$46K	Buy	3,429 +117	+4%	+$1.37K	﹤0.01%	1001
2016 Q2	$36K	Sell	3,312 -208	-6%	-$2.03K	﹤0.01%	1052
2016 Q1	$32K	Buy	3,520 +2,376	+208%	+$19.6K	﹤0.01%	1109
2015 Q4	$11K	Sell	1,144 -400	-26%	-$3.87K	﹤0.01%	1254
2015 Q3	$13K	Hold	1,544	–	–	﹤0.01%	1142
2015 Q2	$16K	Buy	1,544 +523	+51%	+$6.08K	﹤0.01%	1225
2015 Q1	$14K	Buy	1,021 +391	+62%	+$5.13K	﹤0.01%	1212
2014 Q4	$8K	Sell	630 -39	-6%	-$446	﹤0.01%	1280
2014 Q3	$7K	Sell	669 -624	-48%	-$7.14K	﹤0.01%	1220
2014 Q2	$17K	Sell	1,293 -1,196	-48%	-$13K	﹤0.01%	1164
2014 Q1	$26K	Buy	+2,489	New	+$28K	﹤0.01%	1249

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's IRWD Position: Q4 2016 in Review

BlackRock Japan increased its Ironwood Pharmaceuticals (IRWD) stake by 14% in Q4 2016, buying an estimated $6.24K and bringing the position to 3,923 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #982.

BlackRock Japan first reported a position in IRWD in Q1 2014 and has held it in 12 quarters since. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

BlackRock Japan held 3,923 shares of Ironwood Pharmaceuticals worth $50K as of Q4 2016.
BlackRock Japan bought 494 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $6.24K.
Ironwood Pharmaceuticals made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #982 holding.
BlackRock Japan first reported a position in Ironwood Pharmaceuticals in Q1 2014 and has held it in 12 quarters since.
163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.